Nx Development Corp.
Imaging agent development for fluorescence-guided brain cancer surgery
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
NX Development Corp develops and commercializes brain cancer imaging solutions for neurosurgeons treating patients with high-grade gliomas. Its flagship agent, Gleolan®, supports fluorescent visualization of malignant tissue during surgery, and the company holds its U.S. market authorization.
At a Glance
Nx Development Corp. is an American manufacturer based in Lexington, KY.
- Where
- Lexington, KY
